| M01AX24 |
M01AX24 Oxaceprol |
| M01AX25 |
M01AX25 chondroitin sulfate |
| M01AX26 |
M01AX26 avocado and soyabean oil, unsaponifiables |
| M01AX68 |
M01AX68 feprazone, combinations |
| M01B |
M01B Anti-inflammatory/antirheumatic agents in combination |
| M01BA |
M01BA Anti-inflammatory/antirheumatic agents in combination with corticosteroids |
| M01BA01 |
M01BA01 phenylbutazone and corticosteroids |
| M01BA02 |
M01BA02 dipyrocetyl and corticosteroids |
| M01BA03 |
M01BA03 acetylsalicylic acid and corticosteroids |
| M01BX |
M01BX Other Antiinflammatory/Antirheumatic Agents In Combination With Other Drugs |
| M01C |
M01C Specific antirheumatic agents |
| M01CA |
M01CA Quinolines |
| M01CA03 |
M01CA03 oxycinchophen |
| M01CB |
M01CB Gold Preparations |
| M01CB01 |
M01CB01 sodium aurothiomalate |
| M01CB02 |
M01CB02 sodium aurotiosulfate |
| M01CB03 |
M01CB03 Auranofin |
| M01CB04 |
M01CB04 aurothioglucose |
| M01CB05 |
M01CB05 aurotioprol |
| M01CC |
M01CC Penicillamine and similar agents |
| M01CC01 |
M01CC01 penicillamine |
| M01CC02 |
M01CC02 bucillamine |
| M01CX |
M01CX Other specific antirheumatic agents |
| M02 |
M02 Topical products for joint and muscular pain |
| M02A |
M02A Topical products for joint and muscular pain |
| M02AA |
M02AA NSAI preparations for topical use |
| M02AA01 |
M02AA01 phenylbutazone |
| M02AA02 |
M02AA02 mofebutazone |
| M02AA03 |
M02AA03 clofezone |
| M02AA04 |
M02AA04 oxyphenbutazone |